LABU Triple Leveraged Biotech Sector ETF
On the 4H Chart LABU is trending up since March 27th. Last week there was a small pullback which was met with more buying activity.
On the volume indicator, the volume now is approximately 10X day by day compared with March's averages. It is this buying that is driving
the bullish momentum. Small-cap speculative biotech companies are in a growth mode right now no matter adverse economic conditions
for those yet to have any earnings. Big pharma is more concerned about federal attempts to further regulate prices than the economy.
On the volume profile, price has ascended to above the high volume trading area on the strength of buyer interest propelling the
momentum. Overall, this looks to be a decent long trade. The target is $ 9.00 the YTD high back in February.
On the volume indicator, the volume now is approximately 10X day by day compared with March's averages. It is this buying that is driving
the bullish momentum. Small-cap speculative biotech companies are in a growth mode right now no matter adverse economic conditions
for those yet to have any earnings. Big pharma is more concerned about federal attempts to further regulate prices than the economy.
On the volume profile, price has ascended to above the high volume trading area on the strength of buyer interest propelling the
momentum. Overall, this looks to be a decent long trade. The target is $ 9.00 the YTD high back in February.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.